1 recruiting. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Recruiting 1 |
Follow Plasmablastic Lymphoma: new trials by email Literature Review of Plasmablastic Lymphoma trials Research Report on Plasmablastic Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma Cyclophosphamide, Daratumumab, Doxorubicin - Plasmablastic Lymphoma, Ann Arbor Stage I Diffuse Large B-Cell Lymphoma | Early Phase 1 | Recruiting | AIDS Malignancy Consortium | 15 | 2021-05-24 | 2026-10-28 |
Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoma, B-Cell (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Non-Hodgkin (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
Cyclophosphamide (1) · Doxorubicin (1) · Etoposide (1) · Prednisone (1) · Vincristine (1) · daratumumab (1) · deltacortene (1) · prednylidene (1)
AIDS Malignancy Consortium (1)
United States (1)
Ariela Noy, MD (1)
UM1CA121947 (1)